Avara Acquires New OTC Solid Dose Capacity in South Carolina

The global CDMO adds a seventh facility to its manufacturing network.

Expanding its international network of development and manufacturing facilities, Connecticut-based Avara Pharmaceutical Services signed an agreement with GlaxoSmithKline (GSK) to acquire the company’s consumer healthcare manufacturing unit in Aiken, South Carolina.

Providing substantial additional solid-dose capacity in support of the CDMO’s overall manufacturing strategy, Avara’s CEO Timothy C. Tyson explained “this acquisition is an important component of our strategic plan and expands our services by adding additional solid-dose capability in the United States, which is in very high demand.”

The facility covers 250,000 sq. ft and was built in 1978. According to GSK, the unit is an established element of the company’s over-the-counter (OTC) manufacturing network, processing 13 consumer brands and more than 125 SKUs and distribution to 56 countries. Among its accomplishments, GSK said the facility and its staff were responsible for “multiple successful Rx to OTC switches.”

"As we celebrate another important milestone, we continue with great confidence to add pharmaceutical services and capabilities with complementary offerings in key regions in this rapidly growing market. Each of our sites have significant professional experience, state of the art capability and a long history of delivering high quality pharmaceuticals that meet or exceed customer expectations and regulatory requirements in every major market around the world. The people who are a part of the Avara team are the key to our long-term success," said Tyson. "We are focused on delivering on our commitments and earning the trust of every customer we deal with."

The acqisiton reflects Avara’s efforts to grow its contract manufacturing and technical services network and further leverage its operational capabilities on a global basis. The South Carolina facility will be the seventh site in Avara’s network, which currently includes: Norwalk, Connecticut; Arecibo, Puerto Rico; Shannon, Ireland; Norman, Oklahoma; Avion, United Kingdom and Liscate, Italy.


Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.